LENZ Therapeutics (LENZ) Operating Leases (2021 - 2026)
LENZ Therapeutics' (LENZ) quarterly Operating Leases came in at $673000.0 in Q1 2026, down 43.06% year-on-year from $1.2 million in Q1 2025, and up 92.29% on a QoQ basis from $350000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Operating Leases (2021 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 6 years of Operating Leases data on file, last reported at $673000.0 in Q1 2026.
- On a quarterly basis, Operating Leases fell 43.06% year-over-year to $673000.0 in Q1 2026; TTM through Mar 2026 was $673000.0, a 43.06% decrease from a year earlier, with the FY2025 full-year figure at $350000.0, down 57.0% from the prior year.
- Operating Leases for Q1 2026 stood at $673000.0, up from $350000.0 in the prior quarter.
- Over the last five years, Operating Leases for LENZ reached as high as $50.6 million in Q2 2023 and fell as low as $156000.0 in Q1 2024.
- Historically, Operating Leases has averaged $7.1 million across 5 years, with a median of $1.1 million in 2024.
- Across the five-year window, Operating Leases surged 1926.6% in 2023 and plunged 98.08% in 2024, its largest moves.
- Year by year, Operating Leases stood at $1.7 million in 2022, then slumped by 89.02% to $192000.0 in 2023, then surged by 323.96% to $814000.0 in 2024, then plunged by 57.0% to $350000.0 in 2025, then soared by 92.29% to $673000.0 in 2026.
- Per Business Quant data, the three most recent Operating Leases figures were $673000.0 in Q1 2026, $350000.0 in Q4 2025, and $954000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | LENZ Therapeutics | 158.34 Mn | 158.34 Mn | 825,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 673,000.00 |
| Dec 31, 2025 | 350,000.00 |
| Sep 30, 2025 | 954,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Mar 31, 2025 | 1.18 Mn |
| Dec 31, 2024 | 814,000.00 |
| Sep 30, 2024 | 953,000.00 |
| Jun 30, 2024 | 1.05 Mn |
| Mar 31, 2024 | 156,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | 49.67 Mn |
| Jun 30, 2023 | 50.63 Mn |
| Mar 31, 2023 | 1.42 Mn |
| Dec 31, 2022 | 1.75 Mn |
| Sep 30, 2022 | 2.45 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 4.50 Mn |
| Dec 31, 2021 | 5.79 Mn |
| Sep 30, 2021 | 4.68 Mn |